Cell Signaling Technology

SignalSlide® Phospho-Met (Tyr1234/1235) IHC Controls

#8118 · $196

100
Citing papers
4.9k
Combined citations
Supplier page Find this product

Research areas

Gastrointestinal Tumor Research and Treatment10Barrier Structure and Function Studies10Sarcoma Diagnosis and Treatment6Cell Adhesion Molecules Research5Cell death mechanisms and regulation5NF-κB Signaling Pathways5Alzheimer's disease research and treatments4Cancer-related Molecular Pathways4

Papers citing this product

1
AZD2171: A Highly Potent, Orally Bioavailable, Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinase Inhibitor for the Treatment of Cancer
Cancer Research·2005·710 cit.·DOI
2
Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours
British Journal of Cancer·2019·165 cit.·DOI
3
Targets of Caspase-6 Activity in Human Neurons and Alzheimer Disease
Molecular & Cellular Proteomics·2008·120 cit.·DOI
4
Phosphoglucomutase 1 inhibits hepatocellular carcinoma progression by regulating glucose trafficking
PLoS Biology·2018·97 cit.·DOI
5
The cortical hem regulates the size and patterning of neocortex
Development·2014·96 cit.·DOI
6
Intracellular Fe2+ accumulation in endothelial cells and pericytes induces blood-brain barrier dysfunction in secondary brain injury after brain hemorrhage
Scientific Reports·2019·94 cit.·DOI
7
Peptide-siRNA nanocomplexes targeting NF-κB subunit p65 suppress nascent experimental arthritis
Journal of Clinical Investigation·2014·93 cit.·DOI
8
Multipoint targeting of the PI3K/mTOR pathway in mesothelioma
British Journal of Cancer·2014·92 cit.·DOI
9
Assessing the Activity of Cediranib, a VEGFR-2/3 Tyrosine Kinase Inhibitor, against VEGFR-1 and Members of the Structurally Related PDGFR Family
Molecular Cancer Therapeutics·2011·88 cit.·DOI
10
VE-cadherin facilitates BMP-induced endothelial cell permeability and signaling
Journal of Cell Science·2015·84 cit.·DOI